BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12208899)

  • 1. High titers of anti-human herpesvirus 8 antibodies in elderly males in an endemic population.
    Plancoulaine S; Abel L; van Beveren M; Gessain A
    J Natl Cancer Inst; 2002 Sep; 94(17):1333-5. PubMed ID: 12208899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases.
    Rezza G; Andreoni M; Dorrucci M; Pezzotti P; Monini P; Zerboni R; Salassa B; Colangeli V; Sarmati L; Nicastri E; Barbanera M; Pristerà R; Aiuti F; Ortona L; Ensoli B
    J Natl Cancer Inst; 1999 Sep; 91(17):1468-74. PubMed ID: 10469747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma.
    Katano H; Iwasaki T; Baba N; Terai M; Mori S; Iwamoto A; Kurata T; Sata T
    J Virol; 2000 Apr; 74(8):3478-85. PubMed ID: 10729121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
    Caterino-de-Araujo A; Magri MC; Manuel RC
    J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia.
    Qunibi W; Al-Furayh O; Almeshari K; Lin SF; Sun R; Heston L; Ross D; Rigsby M; Miller G
    Transplantation; 1998 Feb; 65(4):583-5. PubMed ID: 9500639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma.
    Martro E; Bulterys M; Stewart JA; Spira TJ; Cannon MJ; Thacher TD; Bruns R; Pellett PE; Dollard SC
    J Med Virol; 2004 Jan; 72(1):126-31. PubMed ID: 14635020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
    Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
    BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area.
    Serraino D; Toma L; Andreoni M; Buttò S; Tchangmena O; Sarmati L; Monini P; Franceschi S; Ensoli B; Rezza G
    Eur J Epidemiol; 2001; 17(9):871-6. PubMed ID: 12081107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with human herpesvirus type 8 and Kaposi's sarcoma in Sardinia.
    Serraino D; Cerimele D; Piselli P; Aztori L; Farchi F; Carletti F; Navarra A; Masala MV; Rezza G
    Infection; 2006 Feb; 34(1):39-42. PubMed ID: 16501902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population.
    Plancoulaine S; Abel L; van Beveren M; Trégouët DA; Joubert M; Tortevoye P; de Thé G; Gessain A
    Lancet; 2000 Sep; 356(9235):1062-5. PubMed ID: 11009141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do fewer cases of Kaposi's sarcoma in HIV-infected patients reflect a decrease in HHV8 seroprevalence?
    Reinheimer C; Allwinn R; Stürmer M
    Med Microbiol Immunol; 2011 Aug; 200(3):161-4. PubMed ID: 21336596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Kaposi's Sarcoma herpesvirus (HHV8) in Västerbotten County, Sweden.
    Tedeschi R; Bidoli E; Agren A; Hallmans G; Wadell G; De Paoli P; Dillner J
    J Med Virol; 2006 Mar; 78(3):372-8. PubMed ID: 16419115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
    Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
    J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma in South Africa.
    Sitas F; Newton R
    J Natl Cancer Inst Monogr; 2001; (28):1-4. PubMed ID: 11158199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York City.
    Engels EA; Clark E; Aledort LM; Goedert JJ; Whitby D
    Int J Epidemiol; 2002 Oct; 31(5):946-50. PubMed ID: 12435765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and immune correlates of human herpesvirus 8 seropositivity in Malawi, Africa.
    DeSantis SM; Pau CP; Archibald LK; Nwanyanwu OC; Kazembe PN; Dobbie H; Jarvis WR; Jason J
    Int J Infect Dis; 2002 Dec; 6(4):266-71. PubMed ID: 12718819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic kaposi sarcoma: epidemiology and risk factors.
    Iscovich J; Boffetta P; Franceschi S; Azizi E; Sarid R
    Cancer; 2000 Feb; 88(3):500-17. PubMed ID: 10649240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
    Lennette ET; Blackbourn DJ; Levy JA
    Lancet; 1996 Sep; 348(9031):858-61. PubMed ID: 8826812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.